- Home
- ASTC vs RDHL Comparison
ASTC vs RDHL Comparison
Compare ASTC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- RDHL
- Stock Information
- Founded
- ASTC 1984
- RDHL 2009
- Country
- ASTC United States
- RDHL Israel
- Employees
- ASTC N/A
- RDHL N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- RDHL Health Care
- Exchange
- ASTC Nasdaq
- RDHL Nasdaq
- Market Cap
- ASTC 11.9M
- RDHL 8.6M
- IPO Year
- ASTC 1995
- RDHL N/A
- Fundamental
- Price
- ASTC $7.27
- RDHL $6.50
- Analyst Decision
- ASTC
- RDHL
- Analyst Count
- ASTC 0
- RDHL 0
- Target Price
- ASTC N/A
- RDHL N/A
- AVG Volume (30 Days)
- ASTC 40.0K
- RDHL 21.6K
- Earning Date
- ASTC 02-10-2025
- RDHL 01-03-2025
- Dividend Yield
- ASTC N/A
- RDHL N/A
- EPS Growth
- ASTC N/A
- RDHL N/A
- EPS
- ASTC N/A
- RDHL N/A
- Revenue
- ASTC $1,273,000.00
- RDHL $3,707,000.00
- Revenue This Year
- ASTC N/A
- RDHL $224.90
- Revenue Next Year
- ASTC N/A
- RDHL $82.69
- P/E Ratio
- ASTC N/A
- RDHL N/A
- Revenue Growth
- ASTC 11.96
- RDHL N/A
- 52 Week Low
- ASTC $6.56
- RDHL $6.00
- 52 Week High
- ASTC $12.29
- RDHL $40.50
- Technical
- Relative Strength Index (RSI)
- ASTC 50.55
- RDHL 38.21
- Support Level
- ASTC $7.04
- RDHL $6.00
- Resistance Level
- ASTC $8.15
- RDHL $7.30
- Average True Range (ATR)
- ASTC 0.47
- RDHL 0.51
- MACD
- ASTC 0.05
- RDHL -0.09
- Stochastic Oscillator
- ASTC 43.23
- RDHL 21.10
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.